English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 11 Help

Selected(0)Clear Items/Page:    Sort:
Changes in Telepsychiatry Regulations during the COVID-19 Pandemic: 17 Countries and Regions' Approaches to an Evolving Healthcare Landscape Journal article
Kinoshita,Shotaro, Cortright,Kelley, Crawford,Allison, Mizuno,Yuya, Yoshida,Kazunari, Hilty,Donald, Guinart,Daniel, Torous,John, Correll,Christoph U., Castle,David J., Rocha,Deyvis, Yang,Yuan, Xiang,Yu Tao, Kølbæk,Pernille, Dines,David, Elshami,Mohammad, Jain,Prakhar, Kallivayalil,Roy, Solmi,Marco, Favaro,Angela, Veronese,Nicola, Seedat,Soraya, Shin,Sangho, De Pablo,Gonzalo Salazar, Chang,Chun Hung, Su,Kuan Pin, Karas,Hakan, Kane,John M., Yellowlees,Peter, Kishimoto,Taishiro. Changes in Telepsychiatry Regulations during the COVID-19 Pandemic: 17 Countries and Regions' Approaches to an Evolving Healthcare Landscape[J]. Psychological Medicine, 2020, 52(13), 2606-2613.
Authors:  Kinoshita,Shotaro;  Cortright,Kelley;  Crawford,Allison;  Mizuno,Yuya;  Yoshida,Kazunari; et al.
Favorite | TC[WOS]:48 TC[Scopus]:53  IF:5.9/6.5 | Submit date：2021/03/02
Covid-19  Government Regulation  Health Insurance Reimbursement  Telemedicine  Telepsychiatry  
Rhythmic low-field magnetic stimulation may improve depression by increasing brain-derived neurotrophic factor Journal article
Xiao,Le, Correll,Christoph U., Feng,Lei, Xiang,Yu Tao, Feng,Yuan, Hu,Chang Qing, Li,Rena, Wang,Gang. Rhythmic low-field magnetic stimulation may improve depression by increasing brain-derived neurotrophic factor[J]. CNS Spectrums, 2019, 24(3), 313-321.
Authors:  Xiao,Le;  Correll,Christoph U.;  Feng,Lei;  Xiang,Yu Tao;  Feng,Yuan; et al.
Favorite | TC[WOS]:10 TC[Scopus]:13  IF:3.4/3.7 | Submit date：2021/03/02
Brain-derived Neurotrophic Factor  Major Depressive Disorder  Mediator  Moderator  Rhythmic Magnetic Stimulation  
Rates and predictors of one-year antipsychotic treatment discontinuation in first-episode schizophrenia: Results from an open-label, randomized, "real world" clinical trial Journal article
Cheng Zhang, Yuan Yanbo, Han Xue, Yang Lei, Zeng Xin, Yang Fude, Lu Zheng, Wang Chuanyue, Deng Hong, Zhao Jingping, Xiang Yu-Tao, Christoph U. Correll, Yu Xin. Rates and predictors of one-year antipsychotic treatment discontinuation in first-episode schizophrenia: Results from an open-label, randomized, "real world" clinical trial[J]. Psychiatry Research, 2019, 273, 631-640.
Authors:  Cheng Zhang;  Yuan Yanbo;  Han Xue;  Yang Lei;  Zeng Xin; et al.
Favorite | TC[WOS]:10 TC[Scopus]:10  IF:4.2/5.3 | Submit date：2020/09/25
First-episode  Antipsychotic  Discontinuation  Predictors  Schizophrenia  
Baseline Characteristics and Early Response at Week 1 Predict Treatment Outcome in Adolescents With Bipolar Manic or Mixed Episode Treated With Olanzapine: Results From a 3-Week, Randomized, Placebo-Controlled Trial Journal article
Xiao, Le, Ganocy, Stephen J., Findling, Robert L., Chang, Kiki, DelBello, Melissa P., Kane, John M., Tohen, Mauricio, Xiang, Yu-Tao, Correll, Christoph U.. Baseline Characteristics and Early Response at Week 1 Predict Treatment Outcome in Adolescents With Bipolar Manic or Mixed Episode Treated With Olanzapine: Results From a 3-Week, Randomized, Placebo-Controlled Trial[J]. JOURNAL OF CLINICAL PSYCHIATRY, 2017, 78(9), E1158-+.
Authors:  Xiao, Le;  Ganocy, Stephen J.;  Findling, Robert L.;  Chang, Kiki;  DelBello, Melissa P.; et al.
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:4.5/5.2 | Submit date：2018/10/30
Biological treatment of acute agitation or aggression with schizophrenia or bipolar disorder in the inpatient setting Journal article
Correll, Christoph U., Yu, Xin, Xiang, Yutao, Kane, John M., Masand, Prakash. Biological treatment of acute agitation or aggression with schizophrenia or bipolar disorder in the inpatient setting[J]. ANNALS OF CLINICAL PSYCHIATRY, 2017, 29(2), 92-107.
Authors:  Correll, Christoph U.;  Yu, Xin;  Xiang, Yutao;  Kane, John M.;  Masand, Prakash
Favorite | TC[WOS]:27 TC[Scopus]:35  IF:1.5/1.6 | Submit date：2018/10/30
Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis Journal article
Galling, Britta, Roldan, Alexandra, Hagi, Katsuhiko, Rietschel, Liz, Walyzada, Frozan, Zheng, Wei, Cao, Xiao-Lan, Xiang, Yu-Tao, Zink, Mathias, Kane, John M., Nielsen, Jimmi, Leucht, Stefan, Correll, Christoph U.. Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis[J]. WORLD PSYCHIATRY, 2017, 16(1), 77-89.
Authors:  Galling, Britta;  Roldan, Alexandra;  Hagi, Katsuhiko;  Rietschel, Liz;  Walyzada, Frozan; et al.
Favorite | TC[WOS]:145 TC[Scopus]:173 | Submit date：2018/10/30
Antipsychotics  Polypharmacy  Augmentation  Monotherapy  Schizophrenia  Clozapine  Aripiprazole  
Efficacy of atypical antipsychotics in the management of acute agitation and aggression in hospitalized patients with schizophrenia or bipolar disorder: results from a systematic review Journal article
Yu,Xin, Correll,Christoph U., Xiang,Yu Tao, Xu,Yifeng, Huang,Jizhong, Yang,Fude, Wang,Gang, Si,Tianmei, Kane,John M., Masand,Prakash. Efficacy of atypical antipsychotics in the management of acute agitation and aggression in hospitalized patients with schizophrenia or bipolar disorder: results from a systematic review[J]. Shanghai Archives of Psychiatry, 2016, 28(5), 241-252.
Authors:  Yu,Xin;  Correll,Christoph U.;  Xiang,Yu Tao;  Xu,Yifeng;  Huang,Jizhong; et al.
Favorite | TC[Scopus]:9
Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: Results from a systematic review and meta-analysis of randomized controlled trials Journal article
Galling,Britta, Roldán,Alexandra, Rietschel,Liz, Hagi,Katsuhiko, Walyzada,Frozan, Zheng,Wei, Cao,Xiao Lan, Xiang,Yu Tao, Kane,John M., Correll,Christoph U.. Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: Results from a systematic review and meta-analysis of randomized controlled trials[J]. Expert Opinion on Drug Safety, 2016, 15(5), 591-612.
Authors:  Galling,Britta;  Roldán,Alexandra;  Rietschel,Liz;  Hagi,Katsuhiko;  Walyzada,Frozan; et al.
Favorite | TC[WOS]:24 TC[Scopus]:28  IF:3.0/3.6 | Submit date：2021/03/02
Adverse Effects  Antipsychotics  Augmentation  Combination  Cotreatment  Metaanalysis  Monotherapy  Polypharmacy  Safety  Schizophrenia  Tolerability  
Worldwide Differences in Regulations of Clozapine Use Journal article
Jimmi Nielsen, Corina Young, Petru Iften, Taishiro Kishimoto, Yu-Tao Xiang, Peter F. J. Schulte, Christoph U. Correll, David Taylor. Worldwide Differences in Regulations of Clozapine Use[J]. CNS Drugs, 2016, 30(2), 149–161.
Authors:  Jimmi Nielsen;  Corina Young;  Petru Iften;  Taishiro Kishimoto;  Yu-Tao Xiang; et al.
Favorite | TC[WOS]:133 TC[Scopus]:143 | Submit date：2019/01/07
Clozapine  Myocarditis  Absolute Neutrophil Count  Schizoaffective Disorder  Agranulocytosis  
Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: Findings of the third national survey on use of psychotropic medications in China Journal article
Li,Qian, Xiang,Yu Tao, Su,Yun Ai, Shu,Liang, Yu,Xin, Chiu,Helen F.K., Correll,Christoph U., Ungvari,Gabor S., Lai,Kelly Y.C., Ma,Cui, Wang,Gao Hua, Bai,Pei Shen, Li,Tao, Sun,Li Zhong, Shi,Jian Guo, Chen,Xian Sheng, Mei,Qi Yi, Li,Ke Qing, Si,Tian Mei. Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: Findings of the third national survey on use of psychotropic medications in China[J]. Australian and New Zealand Journal of Psychiatry, 2015, 49(2), 129-136.
Authors:  Li,Qian;  Xiang,Yu Tao;  Su,Yun Ai;  Shu,Liang;  Yu,Xin; et al.
Favorite | TC[WOS]:37 TC[Scopus]:40  IF:4.0/4.9 | Submit date：2021/03/02
Antipsychotic Polypharmacy  Prescription Patterns  Schizophrenia